Pedal Artery Angioplasty: Beneficial in Critical Limb Ischemia

Courtesy of Dr. Carlos Fava.

Pedal Artery Angioplasty: Beneficial in Critical Limb Ischemia

Delaying or failing to heal trophic wounds in critical limb ischemia (CLI) changes quality of life, delays rehabilitation and is associated to infections and amputation.

 

Pedal artery revascularization with angioplasty would speed up recovery and improve CLI wound healing.

 

The study analyzed 257 patients with de novo infrapopliteal lesions receiving PCI for CLI. 140 of these patients (54.5%) received pedal artery angioplasty (PAA).

 

Mean age was 73, all patients were in Rutherford class 5 or 6, and one third of patients presented >3 mg/dl creatinine. There were no differences in type, location depth or infection of trophic wounds.

 

Angiosome direct revascularization was successful in 60.3% of the population. In PAA patients, ankle brachial index (0.88 vs. 0.81; p=0.004) and skin perfusion pressure was higher (49.3 mmHg vs. 41.9 mmHg; p=0.02).

 

At one year follow up, limb salvage was 88.5% and amputation free survival rate was 73.5%. Wound resolution was 49.5%. In the moderate risk group, pedal artery revascularization saw better resolution of trophic wounds and better time to wound healing (59.3% vs. 38.1%; p=0.003 y 211 vs. 365 days; p=0.008).

 

Independent predictors of delayed healing were:

  • non ambulatory status
  • wound depth (UT ≥2)
  • the need for hemodialysis

 

Conclusion

Patients receiving pedal artery angioplasty showed higher trophic wound healing and better time to healing. As regards wound healing, this aggressive strategy could become a salvage procedure for patients with CLI and pedal artery disease.

 

Editorial Comment

Critical Limb Ischemia is on the rise, and in this analysis, a more aggressive angioplasty procedure showed benefits, especially in high risk groups.

 

It is important to have programs for this group of patients and to familiarize with wound classification, depth and infection presence (UT and WIFI classifications) to be able to better assess strategies.

 

Courtesy of Dr. Carlos Fava. Favaloro Foundation, Buenos Aires, Argentina.

 

Original Title: Clinical Outcome of Pedal Artery Angioplasty for Patients with Ischemic Wounds

Results from the Multicenter RENDEZVOUZ Registry.

Reference: Tatsuya Nakama, et al. J Am Coll Cardiol Intv 2017;10:79-90.


Suscríbase a nuestro newsletter semanal

Reciba resúmenes con los últimos artículos científicos

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...